Delving into the Latest Updates on China Gateway Biologics (Shanghai) Co., Ltd. with Synapse

Overview

Tags

Neoplasms

Bispecific antibody

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Neoplasms	1

Top 5 Drug Type	Count

Bispecific antibody	1

Top 5 Target	Count

CD47 x PDL1	1

主要目的： 1) 评估注射用SG12473 在晚期恶性肿瘤患者中的安全性和耐受性； 2) 确定注射用SG12473 静脉给药在晚期恶性肿瘤患者中的最大耐受剂量（MTD）和/或II 期推荐剂量（RP2D）（Ia 期）。次要目的： 1) 评估注射用SG12473 在晚期恶性肿瘤患者中的药代动力学特征； 2) 评估注射用SG12473 在晚期恶性肿瘤患者中的药效动力学特征； 3) 评估注射用SG12473 在晚期恶性肿瘤患者中的免疫原性； 4) 初步评价注射用SG12473 在晚期恶性肿瘤患者中的疗效。探索性目的：探索肿瘤组织/血液中潜在预测注射用SG12473 疗效的生物标志物。

[Translation]

Primary objectives: 1) To evaluate the safety and tolerability of SG12473 for injection in patients with advanced malignancies; 2) To determine the maximum tolerated dose (MTD) and/or recommended phase II dose (RP2D) (Phase Ia) of SG12473 for injection for intravenous administration in patients with advanced malignancies. Secondary objectives: 1) To evaluate the pharmacokinetic characteristics of SG12473 for injection in patients with advanced malignancies; 2) To evaluate the pharmacodynamic characteristics of SG12473 for injection in patients with advanced malignancies; 3) To evaluate the immunogenicity of SG12473 for injection in patients with advanced malignancies; 4) To preliminarily evaluate the efficacy of SG12473 for injection in patients with advanced malignancies. Exploratory objectives: To explore biomarkers in tumor tissue/blood that may potentially predict the efficacy of SG12473 for injection.

Start Date01 Jul 2021

Sponsor / Collaborator

China Gateway Biologics (Shanghai) Co., Ltd.

[+1]

100 Clinical Results associated with China Gateway Biologics (Shanghai) Co., Ltd.

Login to view more data

0 Patents (Medical) associated with China Gateway Biologics (Shanghai) Co., Ltd.

Login to view more data

100 Deals associated with China Gateway Biologics (Shanghai) Co., Ltd.

Login to view more data

100 Translational Medicine associated with China Gateway Biologics (Shanghai) Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 1 Clinical

1

Login to view more data